Literature DB >> 23282393

Pathogenesis of intestinal strictures in Crohn's disease-an update.

M F Graham1.   

Abstract

: Stricture formation in Crohn's disease is a complication of an important wound healing process in the intestine. The smooth muscle cells of the intestinal musculares bear a responsibility for the repair of injured intestine, and effect this wound healing process by proliferating and laying down collagen at the site of injury. Injury in the submucosa, and chronicity of injury, are important factors in the development of stricture. The resultant accumulation of collagenous scar, thickening of the muscle layers, and contracture, all play a role in producing the critical architectural changes in the intestinal wall that impede the aboral movement of chyme. Important putative facets of intestinal smooth muscle cell biology that are involved in stricture formation include: the synthesis and secretion of procollagen; the peculiar response of these cells to cytokines, ascorbate, and corticosteroids; and changes in cell phenotype that result from chronic inflammation. Therapeutic modalities designed to ameliorate the stricturing process will need to modulate these biological activities in resident intestinal smooth muscle cells.

Entities:  

Year:  1995        PMID: 23282393

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  15 in total

1.  Drug-induced fibrosing colonopathy in inflammatory bowel disease after 5-ASA?

Authors:  H Allgayer; P Böhne; W Kruis
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

2.  Phenotypic change and accumulation of smooth muscle cells in strictures in Crohn's disease: relevance to local angiotensin II system.

Authors:  Takehisa Suekane; Yoshihiro Ikura; Kenji Watanabe; Junko Arimoto; Yoko Iwasa; Yoshimi Sugama; Soichiro Kayo; Kenichi Sugioka; Takahiko Naruko; Kiyoshi Maeda; Kosei Hirakawa; Tetsuo Arakawa; Makiko Ueda
Journal:  J Gastroenterol       Date:  2010-04-02       Impact factor: 7.527

Review 3.  Diagnostic accuracy of fecal lactoferrin for inflammatory bowel disease: a meta-analysis.

Authors:  Yan Wang; Fengyan Pei; Xingjuan Wang; Zhiyu Sun; Chengjin Hu; Hengli Dou
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 4.  Wound healing and fibrosis in intestinal disease.

Authors:  F Rieder; J Brenmoehl; S Leeb; J Schölmerich; G Rogler
Journal:  Gut       Date:  2007-01       Impact factor: 23.059

Review 5.  Maintenance of radiation-induced intestinal fibrosis: cellular and molecular features.

Authors:  Valérie Haydont; Marie-Catherine Vozenin-Brotons
Journal:  World J Gastroenterol       Date:  2007-05-21       Impact factor: 5.742

6.  Inhibition of Rho kinase modulates radiation induced fibrogenic phenotype in intestinal smooth muscle cells through alteration of the cytoskeleton and connective tissue growth factor expression.

Authors:  C Bourgier; V Haydont; F Milliat; A François; V Holler; P Lasser; J Bourhis; D Mathé; M-C Vozenin-Brotons
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

7.  Evidence of delayed gastrointestinal syndrome in high-dose irradiated mice.

Authors:  Catherine Booth; Gregory Tudor; Nicola Tonge; Terez Shea-Donohue; Thomas J MacVittie
Journal:  Health Phys       Date:  2012-10       Impact factor: 1.316

8.  Effect of infliximab on small bowel stenoses in patients with Crohn's disease.

Authors:  Nadia Pallotta; Fausto Barberani; Naima-Abdulkadir Hassan; Danila Guagnozzi; Giuseppina Vincoli; Enrico Corazziari
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

9.  Irsogladine maleate ameliorates inflammation and fibrosis in mice with chronic colitis induced by dextran sulfate sodium.

Authors:  Hana Yamaguchi; Kenji Suzuki; Masaki Nagata; Tomoyuki Kawase; Vijayakumar Sukumaran; Rajarajan A Thandavarayan; Yusuke Kawauchi; Junji Yokoyama; Masayuki Tomita; Hiroshi Kawachi; Kenichi Watanabe; Hiroyuki Yoneyama; Hitoshi Asakura; Ritsuo Takagi
Journal:  Med Mol Morphol       Date:  2012-09-22       Impact factor: 2.309

10.  Halofuginone, a specific inhibitor of collagen type 1 synthesis, ameliorates oxidant colonic damage in rats with experimental colitis.

Authors:  Berna Karakoyun; Meral Yüksel; Feriha Ercan; Emine Salva; Işil Işik; Berrak C Yeğen
Journal:  Dig Dis Sci       Date:  2009-04-24       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.